Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicole Basset-Seguin

Showing results (1-10 of 105) with videos related to

Pageof 11
Sort By:
European Journal of Dermatology : EJD|December 28, 2012
[The real face of actinic keratosis: field of cancerisation and squamous cell carcinoma]Nicole Basset-Seguin
Expert Opinion on Emerging Drugs|January 8, 2021
Emerging drugs for the treatment of basal cell carcinomaFlorian Herms, Nicole Basset-Seguin
Acta Dermato-Venereologica|April 30, 2020
Update in the Management of Basal Cell CarcinomaNicole Basset-Seguin, Florian Herms
Cancers|February 15, 2022
Recent Advanced in the Treatment of Advanced SCC TumorsNicole Basset-Seguin, Eve Maubec
Future Oncology (London, England)|November 15, 2023
Response to "<i>Hedgehog pathway inhibitor real-world treatment patterns in patients with basal cell carcinoma: a claims-based analysis</i>"Florian Herms, Nicole Basset-Seguin
Medecine Sciences : M/S|October 6, 2004
[Patched/Sonic Hedgehog pathway and basal cell carcinoma]Nicole Basset-Seguin, Nadem Soufir
La Revue Du Praticien|March 22, 2014
[Basal cell carcinomas]Catherine Renaud-Vilmer, Nicole Basset-Seguin
Cancer Treatment and Research|May 6, 2009
New trends in the susceptibility to melanomaNadem Soufir, Bernard Grandchamp, Nicole Basset-Seguin
Archives of Dermatology|October 20, 2010
ISET device: a useful tool to answer some questions about the biologic behavior of melanocytic nevus cellsVincent Descamps, Nicole Basset-Seguin, Nadem Soufir
European Journal of Dermatology : EJD|February 13, 2013
The France-PDT study: a national prospective observational cohort survey on the use of methyl-aminolevulinate photodynamic therapy in France, with up to 6-month follow-upDavid Farhi, Christophe Bedane, Jacques Savary, et al.
Pageof 11

Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
European Journal of Dermatology : EJD|December 28, 2012
[The real face of actinic keratosis: field of cancerisation and squamous cell carcinoma]Nicole Basset-Seguin
Expert Opinion on Emerging Drugs|January 8, 2021
Emerging drugs for the treatment of basal cell carcinomaFlorian Herms, Nicole Basset-Seguin
Acta Dermato-Venereologica|April 30, 2020
Update in the Management of Basal Cell CarcinomaNicole Basset-Seguin, Florian Herms
Cancers|February 15, 2022
Recent Advanced in the Treatment of Advanced SCC TumorsNicole Basset-Seguin, Eve Maubec
Future Oncology (London, England)|November 15, 2023
Response to "<i>Hedgehog pathway inhibitor real-world treatment patterns in patients with basal cell carcinoma: a claims-based analysis</i>"Florian Herms, Nicole Basset-Seguin
Medecine Sciences : M/S|October 6, 2004
[Patched/Sonic Hedgehog pathway and basal cell carcinoma]Nicole Basset-Seguin, Nadem Soufir
La Revue Du Praticien|March 22, 2014
[Basal cell carcinomas]Catherine Renaud-Vilmer, Nicole Basset-Seguin
Cancer Treatment and Research|May 6, 2009
New trends in the susceptibility to melanomaNadem Soufir, Bernard Grandchamp, Nicole Basset-Seguin
Archives of Dermatology|October 20, 2010
ISET device: a useful tool to answer some questions about the biologic behavior of melanocytic nevus cellsVincent Descamps, Nicole Basset-Seguin, Nadem Soufir
European Journal of Dermatology : EJD|February 13, 2013
The France-PDT study: a national prospective observational cohort survey on the use of methyl-aminolevulinate photodynamic therapy in France, with up to 6-month follow-upDavid Farhi, Christophe Bedane, Jacques Savary, et al.
Pageof 11